Personal tools

Coexpression cluster:C172: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C172_chorionic_skeletal_tongue_amniotic_liver_gastrointestinal_Pericytes |id=C172 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C172_chorionic_skeletal_tongue_amniotic_liver_gastrointestinal_Pericytes
|full_id=C172_chorionic_skeletal_tongue_amniotic_liver_gastrointestinal_Pericytes
|gostat_on_coexpression_clusters=GO:0006349!genetic imprinting!0.00323796067349582!3481$GO:0018445!prothoracicotrophic hormone activity!0.00323796067349582!3481$GO:0005159!insulin-like growth factor receptor binding!0.00323796067349582!3481$GO:0008286!insulin receptor signaling pathway!0.00582832921229247!3481$GO:0005184!neuropeptide hormone activity!0.00582832921229247!3481$GO:0040029!regulation of gene expression, epigenetic!0.00956670198987401!3481$GO:0001501!skeletal development!0.0212920444287452!3481$GO:0007169!transmembrane receptor protein tyrosine kinase signaling pathway!0.0212920444287452!3481$GO:0005179!hormone activity!0.0212920444287452!3481$GO:0008083!growth factor activity!0.0223419286471212!3481$GO:0007167!enzyme linked receptor protein signaling pathway!0.024084005009473!3481
|id=C172
|id=C172
}}
}}

Revision as of 17:35, 18 May 2012


Full id: C172_chorionic_skeletal_tongue_amniotic_liver_gastrointestinal_Pericytes



Phase1 CAGE Peaks

Hg19::chr11:2150745..2150785,+p1@BC127839
Hg19::chr11:2151798..2151813,-p2@IGF2
Hg19::chr11:2151877..2151902,+p@chr11:2151877..2151902
+
Hg19::chr11:2151947..2151958,+p@chr11:2151947..2151958
+
Hg19::chr11:2152575..2152590,+p@chr11:2152575..2152590
+
Hg19::chr11:2152641..2152652,+p@chr11:2152641..2152652
+
Hg19::chr11:2152665..2152693,+p27@IGF2
Hg19::chr11:2152702..2152747,+p17@IGF2
Hg19::chr11:2152775..2152817,+p14@IGF2
Hg19::chr11:2152829..2152834,+p57@IGF2
Hg19::chr11:2152856..2152896,+p21@IGF2
Hg19::chr11:2152902..2152970,+p13@IGF2
Hg19::chr11:2152974..2153103,+p10@IGF2
Hg19::chr11:2153071..2153082,-p8@IGF2
Hg19::chr11:2153108..2153139,+p29@IGF2
Hg19::chr11:2153157..2153189,+p26@IGF2
Hg19::chr11:2153165..2153178,-p11@IGF2
Hg19::chr11:2153201..2153247,+p18@IGF2
Hg19::chr11:2153253..2153337,+p15@IGF2
Hg19::chr11:2153332..2153354,-p6@IGF2
Hg19::chr11:2153356..2153374,-p7@IGF2
Hg19::chr11:2153389..2153416,-p4@IGF2
Hg19::chr11:2153449..2153463,-p5@IGF2
Hg19::chr11:2153576..2153579,-p@chr11:2153576..2153579
-
Hg19::chr11:2153590..2153601,-p@chr11:2153590..2153601
-
Hg19::chr11:2153605..2153619,-p@chr11:2153605..2153619
-
Hg19::chr11:2153817..2153828,+p3@BC075845
Hg19::chr11:2153850..2153861,+p2@BC075845
Hg19::chr11:2153890..2153941,+p1@BC075845
p2@BC021076
Hg19::chr11:2153950..2153990,+p1@BC021076
Hg19::chr11:2154002..2154014,+p3@BC021076
Hg19::chr11:2154041..2154052,+p4@BC021076
Hg19::chr11:2154088..2154099,+p5@CU674261
Hg19::chr11:2154095..2154106,-p@chr11:2154095..2154106
-
Hg19::chr11:2154106..2154118,+p3@CU674261
Hg19::chr11:2154122..2154138,+p4@CU674261
Hg19::chr11:2154145..2154155,+p7@CU674261
Hg19::chr11:2154203..2154221,+p2@CU674261
Hg19::chr11:2154248..2154285,+p1@CU674261
Hg19::chr11:2154382..2154391,+p6@CU674261
Hg19::chr11:2154762..2154797,+p@chr11:2154762..2154797
+
Hg19::chr11:2154767..2154781,-p36@IGF2
Hg19::chr11:2154790..2154814,-p24@IGF2
Hg19::chr11:2154832..2154852,-p44@IGF2
Hg19::chr11:2154872..2154893,-p38@IGF2
Hg19::chr11:2156633..2156657,-p32@IGF2
Hg19::chr11:2156660..2156669,-p64@IGF2
Hg19::chr11:2156671..2156708,-p40@IGF2
Hg19::chr11:2156713..2156749,-p37@IGF2
Hg19::chr11:2156751..2156773,-p55@IGF2
Hg19::chr11:2159479..2159489,-p54@IGF2
Hg19::chr11:2159491..2159532,-p23@IGF2
Hg19::chr11:2159538..2159595,-p12@IGF2
Hg19::chr11:2159572..2159583,+p20@BC017277
Hg19::chr11:2159607..2159615,-p1@X06260
Hg19::chr11:2159622..2159637,+p8@BC017277
Hg19::chr11:2159650..2159672,+p9@BC017277
Hg19::chr11:2159658..2159696,-p28@IGF2
Hg19::chr11:2159675..2159689,+p11@BC017277
Hg19::chr11:2159697..2159702,-p58@IGF2
Hg19::chr11:2159700..2159730,+p6@BC017277
Hg19::chr11:2159738..2159755,-p43@IGF2
Hg19::chr11:2159748..2159761,+p12@BC017277
Hg19::chr11:2159760..2159769,-p42@IGF2
Hg19::chr11:2159773..2159793,-p33@IGF2
Hg19::chr11:2159808..2159810,-p62@IGF2
Hg19::chr11:2159814..2159825,+p14@BC017277
Hg19::chr11:2159824..2159832,-p39@IGF2
Hg19::chr11:2159834..2159900,-p9@IGF2
Hg19::chr11:2159838..2159847,+p16@BC017277
Hg19::chr11:2159872..2159877,+p18@BC017277
Hg19::chr11:2159911..2159935,-p22@IGF2
Hg19::chr11:2159935..2159950,+p5@BC017277
Hg19::chr11:2159947..2159948,-p71@IGF2
Hg19::chr11:2159954..2159960,-p46@IGF2
Hg19::chr11:2159969..2159986,+p2@BC017277
Hg19::chr11:2159997..2160004,+p15@BC017277
Hg19::chr11:2160010..2160024,+p10@BC017277
Hg19::chr11:2160019..2160028,-p48@IGF2
Hg19::chr11:2160036..2160049,+p7@BC017277
Hg19::chr11:2160043..2160076,-p25@IGF2
Hg19::chr11:2160078..2160088,-p52@IGF2
Hg19::chr11:2160094..2160100,-p53@IGF2
Hg19::chr11:2160098..2160115,+p4@BC017277
Hg19::chr11:2160117..2160121,-p30@IGF2
Hg19::chr11:2160161..2160172,-p34@IGF2
Hg19::chr11:2160180..2160257,-p19@IGF2
Hg19::chr11:2160283..2160292,+p19@BC017277
Hg19::chr11:2160293..2160310,+p3@BC017277
Hg19::chr11:2160337..2160349,+p13@BC017277
Hg19::chr11:2160354..2160387,+p1@BC017277
Hg19::chr11:2160369..2160383,-p20@IGF2
Hg19::chr11:2160430..2160435,-p41@IGF2
Hg19::chr11:2160468..2160486,-p35@IGF2
Hg19::chr11:2160485..2160488,+p21@BC017277
Hg19::chr11:2160500..2160515,-p47@IGF2
Hg19::chr11:2160520..2160531,-p50@IGF2
Hg19::chr11:2160538..2160549,-p45@IGF2
Hg19::chr11:2160567..2160571,-p51@IGF2
Hg19::chr11:2160611..2160656,-p1@IGF2
Hg19::chr11:2162486..2162497,-p56@IGF2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006349genetic imprinting0.00323796067349582
GO:0018445prothoracicotrophic hormone activity0.00323796067349582
GO:0005159insulin-like growth factor receptor binding0.00323796067349582
GO:0008286insulin receptor signaling pathway0.00582832921229247
GO:0005184neuropeptide hormone activity0.00582832921229247
GO:0040029regulation of gene expression, epigenetic0.00956670198987401
GO:0001501skeletal development0.0212920444287452
GO:0007169transmembrane receptor protein tyrosine kinase signaling pathway0.0212920444287452
GO:0005179hormone activity0.0212920444287452
GO:0008083growth factor activity0.0223419286471212
GO:0007167enzyme linked receptor protein signaling pathway0.024084005009473



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.